Subclinical inflammation during third trimester of pregnancy was not associated with markers of the metabolic syndrome in young adult offspring

Obesity

Volumn 22, Issue 5, 2014, Pages 1351-1358

  Danielsen, Inge ^a,b   Granström, Charlotta ^b   Rytter, Dorte ^c   Halldorsson, Thorhallur I ^b,d   Bech, Bodil Hammer ^c   Henriksen, Tine Brink ^e   Stehouwer, Coen D A ^f   Schalkwijk, Casper G ^f   Vaag, Allan A ^a,g   Olsen, Sjurdur F ^b  

^a Rigshospitalet   (Denmark)

^b STATENS SERUM INSTITUT   (Denmark)

^c AARHUS UNIVERSITY   (Denmark)

^d UNIVERSITY OF ICELAND   (Iceland)

^e AARHUS UNIVERSITY HOSPITAL   (Denmark)

^f MAASTRICHT UNIVERSITY   (Netherlands)

^g UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; LEPTIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA; BIOLOGICAL MARKER; CHOLESTEROL; GLUCOSE BLOOD LEVEL;

ADULT; ARTICLE; BODY HEIGHT; BODY MASS; CHOLESTEROL BLOOD LEVEL; CLINICAL ASSESSMENT TOOL; COHORT ANALYSIS; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; DISEASE MARKER; EDUCATIONAL STATUS; FEMALE; GESTATIONAL AGE; GLUCOSE BLOOD LEVEL; HIGH RISK PREGNANCY; HOMEOSTASIS MODEL ASSESSMENT FOR INSULIN RESISTANCE; HORMONE BLOOD LEVEL; HUMAN; INFLAMMATION; INSULIN BLOOD LEVEL; MALE; MATERNAL SMOKING; METABOLIC SYNDROME X; OUTCOME ASSESSMENT; PREGNANCY OUTCOME; PRENATAL EXPOSURE; PREPREGNANCY CARE; PROGENY; PROTEIN BLOOD LEVEL; RISK ASSESSMENT; SYSTOLIC BLOOD PRESSURE; THIRD TRIMESTER PREGNANCY; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE; YOUNG ADULT; BLOOD; BLOOD PRESSURE; FOLLOW UP; INSULIN RESISTANCE; LONGITUDINAL STUDY; METABOLISM; MULTIVARIATE ANALYSIS; PREGNANCY; STATISTICAL MODEL;

ADULT; BIOLOGICAL MARKERS; BLOOD GLUCOSE; BLOOD PRESSURE; BODY MASS INDEX; C-REACTIVE PROTEIN; CHOLESTEROL; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFLAMMATION; INSULIN; INSULIN RESISTANCE; INTERLEUKIN-1BETA; INTERLEUKIN-6; LEPTIN; LINEAR MODELS; LONGITUDINAL STUDIES; MALE; METABOLIC SYNDROME X; MULTIVARIATE ANALYSIS; PREGNANCY; PREGNANCY TRIMESTER, THIRD; TRIGLYCERIDES; TUMOR NECROSIS FACTOR-ALPHA; WAIST CIRCUMFERENCE; YOUNG ADULT;

EID: 84899970640     PISSN: 19307381     EISSN: 1930739X     Source Type: Journal    
DOI: 10.1002/oby.20650     Document Type: Article

References (40)

1. Clausen TD, Mathiesen ER, Hansen T, et al. High prevalence of type 2 diabetes and pre-diabetes in adult offspring of women with gestational diabetes mellitus or type 1 diabetes: the role of intrauterine hyperglycemia. Diabetes Care 2008; 31: 340-346.
2. Akash MS, Shen Q, Rehman K, Chen S,. Interleukin-1 receptor antagonist: a new therapy for type 2 diabetes mellitus. J Pharm Sci 2012; 101: 1647-1658.
3. Clendenen TV, Koenig KL, Arslan AA, et al. Factors associated with inflammation markers, a cross-sectional analysis. Cytokine 2011; 56: 769-778.
4. Corrado E, Rizzo M, Aluigi L, et al. Prediction of vascular events in subjects with subclinical atherosclerosis and the metabolic syndrome: the role of markers of inflammation. Int Angiol 2012; 31: 219-226.
5. Dallmeier D, Larson M, Vasan R, et al. Metabolic syndrome and inflammatory biomarkers: a community-based cross-sectional study at the Framingham Heart Study. Diabetol Metab Syndr 2012; 4: 28.
6. Donath MY, Schumann DM, Faulenbach M, Ellingsgaard H, Perren A, Ehses JA,. Islet inflammation in type 2 diabetes: from metabolic stress to therapy. Diabetes Care 2008; 31: S161-S164.
7. Herder C, Brunner EJ, Rathmann W, et al. Elevated levels of the anti-inflammatory interleukin-1 receptor antagonist precede the onset of type 2 diabetes: the Whitehall II study. Diabetes Care 2009; 32: 421-423.
8. Hu FB, Meigs JB, Li TY, Rifai N, Manson JE,. Inflammatory markers and risk of developing type 2 diabetes in women. Diabetes 2004; 53: 693-700.
9. Spranger J, Kroke A, Mohlig M, et al. Inflammatory cytokines and the risk to develop type 2 diabetes: results of the prospective population-based European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam Study. Diabetes 2003; 52: 812-817.
10. Ruotsalainen E, Salmenniemi U, Vauhkonen I, et al. Changes in inflammatory cytokines are related to impaired glucose tolerance in offspring of type 2 diabetic subjects. Diabetes Care 2006; 29: 2714-2720.
11. Sen S, Simmons RA,. Maternal antioxidant supplementation prevents adiposity in the offspring of Western diet-fed rats. Diabetes 2010; 59: 3058-3065.
12. International Diabetes Federation, available at http://www.idf.org/ webdata/docs/MetS-def-update2006.pdf. 2012.
13. Ford ES,. Risks for all-cause mortality, cardiovascular disease, and diabetes associated with the metabolic syndrome: a summary of the evidence. Diabetes Care 2005; 28: 1769-1778.
14. Warner MJ, Ozanne SE,. Mechanisms involved in the developmental programming of adulthood disease. Biochem J 2010; 427: 333-347.
15. Poston L,. Intergenerational transmission of insulin resistance and type 2 diabetes. Prog Biophys Mol Biol 2011; 106: 315-322.
16. Luo ZC, Nuyt AM, Delvin E, et al. Maternal and fetal leptin, adiponectin levels and associations with fetal insulin sensitivity. Obesity (Silver Spring) 2013; 21: 210-216.
17. Denney JM, Nelson EL, Wadhwa PD, et al. Longitudinal modulation of immune system cytokine profile during pregnancy. Cytokine 2011; 53: 170-177.
18. Mor G, Cardenas I, Abrahams V, Guller S,. Inflammation and pregnancy: the role of the immune system at the implantation site. Ann N Y Acad Sci 2011; 1221: 80-87.
19. Xiao JP, Yin YX, Gao YF, et al. The increased maternal serum levels of IL-6 are associated with the severity and onset of preeclampsia. Cytokine 2012; 60: 856-860.
20. Xie C, Yao MZ, Liu JB, Xiong LK,. A meta-analysis of tumor necrosis factor-alpha, interleukin-6, and interleukin-10 in preeclampsia. Cytokine 2011; 56: 550-559.
21. Coussons-Read ME, Lobel M, Carey JC, et al. The occurrence of preterm delivery is linked to pregnancy-specific distress and elevated inflammatory markers across gestation. Brain Behav Immun 2012; 26: 650-659.
22. Sorokin Y, Romero R, Mele L, et al. Maternal serum interleukin-6, C-reactive protein, and matrix metalloproteinase-9 concentrations as risk factors for preterm birth <32 weeks and adverse neonatal outcomes. Am J Perinatol 2010; 27: 631-640.
23. Pitiphat W, Gillman MW, Joshipura KJ, et al. Plasma C-reactive protein in early pregnancy and preterm delivery. Am J Epidemiol 2005; 162: 1108-1113.
24. Geelhoed JJ, Fraser A, Tilling K, et al. Preeclampsia and gestational hypertension are associated with childhood blood pressure independently of family adiposity measures: the Avon Longitudinal Study of Parents and Children. Circulation 2010; 122: 1192-1199.
25. Kajantie E, Eriksson JG, Osmond C, Thornburg K, Barker DJ,. Pre-eclampsia is associated with increased risk of stroke in the adult offspring: the Helsinki birth cohort study. Stroke 2009; 40: 1176-1180.
26. Olsen SF, Hansen HS, Sandstrom B, Jensen B,. Erythrocyte levels compared with reported dietary intake of marine n-3 fatty acids in pregnant women. Br J Nutr 1995; 73: 387-395.
27. te Velde SJ, Ferreira I, Twisk JW, Stehouwer CD, van MW, Kemper, HC,. Birthweight and arterial stiffness and blood pressure in adulthood-results from the Amsterdam Growth and Health Longitudinal Study. Int J Epidemiol 2004; 33: 154-161.
28. van Bussel BC, Schouten F, Henry RM, et al. Endothelial dysfunction and low-grade inflammation are associated with greater arterial stiffness over a 6-year period. Hypertension 2011; 58: 588-595.
29. Frystyk J, Tarnow L, Hansen TK, Parving HH, Flyvbjerg A,. Increased serum adiponectin levels in type 1 diabetic patients with microvascular complications. Diabetologia 2005; 48: 1911-1918.
30. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC,. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412-419.
31. Willett WC, Howe GR, Kushi LH,. Adjustment for total energy intake in epidemiologic studies. Am J Clin Nutr 1997; 65: 1220S-1228S.
32. Hales CN, Barker DJ,. The thrifty phenotype hypothesis. Br Med Bull 2001; 60: 5-20.
33. Poston L,. Developmental programming and diabetes-the human experience and insight from animal models. Best Pract Res Clin Endocrinol Metab 2010; 24: 541-552.
34. Kaaja R, Laivuori H, Pulkki P, Tikkanen MJ, Hiilesmaa V, Ylikorkala O,. Is there any link between insulin resistance and inflammation in established preeclampsia? Metabolism 2004; 53: 1433-1435.
35. Kirwan JP, Hauguel-De MS, Lepercq J, et al. TNF-alpha is a predictor of insulin resistance in human pregnancy. Diabetes 2002; 51: 2207-2213.
36. Power ML, Schulkin J,. Maternal obesity, metabolic disease, and allostatic load. Physiol Behav 2012; 106: 22-28.
37. Visvanathan S, Rahman MU, Hoffman GS, et al. Tissue and serum markers of inflammation during the follow-up of patients with giant-cell arteritis-a prospective longitudinal study. Rheumatology (Oxford) 2011; 50: 2061-2070.
38. Lasselin J, Laye S, Dexpert S, et al. Fatigue symptoms relate to systemic inflammation in patients with type 2 diabetes. Brain Behav Immun 2012; 26: 1211-1219.
39. Rysz J, Banach M, Cialkowska-Rysz A, et al. Blood serum levels of IL-2, IL-6, IL-8, TNF-alpha and IL-1beta in patients on maintenance hemodialysis. Cell Mol Immunol 2006; 3: 151-154.
40. Roseman C, Truedsson L, Kapetanovic MC,. The effect of smoking and alcohol consumption on markers of systemic inflammation, immunoglobulin levels and immune response following pneumococcal vaccination in patients with arthritis. Arthritis Res Ther 2012; 14: R170.